2020
DOI: 10.1016/j.npep.2019.102001
|View full text |Cite
|
Sign up to set email alerts
|

Activation of NPY receptor subtype 1 by [D-His26]NPY is sufficient to prevent development of anxiety and depressive like effects in the single prolonged stress rodent model of PTSD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 69 publications
0
19
0
Order By: Relevance
“…Also, HDAC activity impairment can lead to an increase in the NPY expression in the central nucleus of amygdala and medial nucleus of amygdala [15]. NPY is a hypothalamic orexigenic neuropeptide which is sufficient to prevent anxiety, social disorders and depressive symptoms [16]. Besides that, NPY and its receptors have been evidenced to impose anti-inflammatory and antidepressant effects on lipopolysaccharidesinduced depression rat models [17].…”
Section: Introductionmentioning
confidence: 99%
“…Also, HDAC activity impairment can lead to an increase in the NPY expression in the central nucleus of amygdala and medial nucleus of amygdala [15]. NPY is a hypothalamic orexigenic neuropeptide which is sufficient to prevent anxiety, social disorders and depressive symptoms [16]. Besides that, NPY and its receptors have been evidenced to impose anti-inflammatory and antidepressant effects on lipopolysaccharidesinduced depression rat models [17].…”
Section: Introductionmentioning
confidence: 99%
“…In rodents, the alleviation of anxiety caused by overexpression of Y1R also corroborates the above findings ( 131 ). Similarly, knockout of Y1R leads to anxiety outcomes ( 132 ), and the intranasal administration of Y1R agonists is sufficient to prevent anxiety ( 133 ). Moreover, specific Y5R agonists were injected into the PVN, resulting in a reduction in anxiety-related behaviors in animals ( 134 ).…”
Section: Npy Indirectly Regulates the Immune Responsementioning
confidence: 99%
“…However, NPY expression in the brain decreases overall during depression ( 13 ). Consequently, intraventricular infusion of NPY or intranasal delivery of NPY to the brain effectively prevents depressive behavior in animal models ( 133 , 141 ). LP-NPY (Y1R and Y5R agonists) is as useful as NPY and presents therapeutic potential in preventing the development of depressive-like behavior ( 142 ).…”
Section: Npy Indirectly Regulates the Immune Responsementioning
confidence: 99%
“…Selective agonist or antagonists of the NPY receptor subtypes have been shown to modulate behaviors associated with stress-disorders. For example, selective agonism of Y1R has been reported to mediate the anxiolytic and anti-depressive effects of NPY [ 38 , 39 , 40 ]. Whereas, Y1R and Y2R appear to regulate responses to conditioned fear [ 41 ].…”
Section: Stress-protective Effects Of Npymentioning
confidence: 99%